MNMD Stock Summary and Trading Ideas (Mind Medicine (Mindmed) - Common Shares | NASDAQ:MNMD)

Mind Medicine Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. It is developing a pipeline of product candidates targeting neurotransmitter pathways that play key roles in brain health disorders. This includes explicitly pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, as its key product candidates. The MM120 is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that is being developed to treat generalized anxiety disorder and clinical depressive disorder, and the MM402 is a proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), being developed to treat autism spectrum disorder (ASD).

Mind Medicine (Mindmed) - Common Shares trades on the NASDAQ stock market under the symbol MNMD.

As of January 16, 2026, MNMD stock price was flat at $15.02 with million shares trading.

MNMD has a beta of 1.81, meaning it tends to be more sensitive to market movements. MNMD has a correlation of 0.17 to the broad based SPY ETF.

MNMD has a market cap of $1.46 billion. This is considered a Small Cap stock.

In the last 3 years, MNMD traded as high as $15.29 and as low as $2.41.

The top ETF exchange traded funds that MNMD belongs to (by Net Assets): IWM, IWN, IWC, ESML, IWV.

MNMD has outperformed the market in the last year with a price return of +130.7% while the SPY ETF gained +18.1%. MNMD has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +26.1% and +10.1%, respectively, while the SPY returned +5.0% and +1.2%, respectively.

MNMD support price is $14.37 and resistance is $15.67 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MNMD shares will trade within this expected range on the day.